Robert, Charleen
Psimaras, Dimitri
Choquet, Sylvain
Bonnefont-Rousselot, Dominique
Alkouri, Rana
Sakka, Mehdi
Denis, Jérôme Alexandre
Marois, Clémence
Houillier, Caroline
Birzu, Cristina
Leprince, Alice
Ricard, Damien
Morel, Véronique
Uzunov, Madalina
Souchet, Laetitia
Boussen, Inès
Baron, Marine
Roos-Weil, Damien
Friser, Valérie
Miranda, Nathalie
Shor, Natalia
Leclercq, Delphine
Decavele, Maxens
Rohaut, Benjamin
Demeret, Sophie
Weiss, Nicolas
Le Guennec, Loïc https://orcid.org/0000-0001-8146-6256
Article History
Received: 5 January 2026
Revised: 6 February 2026
Accepted: 7 February 2026
First Online: 17 February 2026
Declarations
:
: Authors have no conflicts of interest to declare in relationship with this manuscript. Nicolas Weiss declares having perceived consultant fees from Alexion and Lucane Pharma. Clemence Marois declares having perceived consultant fees from Alexion, Johnson and Johnson, and UCB. Caroline Houillier: consultant fees from Serb, BMS, and Kite Gilead.
: Not applicable.